Thermo Fisher Scientific Stock News

Balasa Dinverno & Foltz LLC increased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 4.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,929 shares of the medical research companys stock after buying an additional 118 shares during the period. []

Mirion Technologies (NYSE:MIR) and Thermo Fisher Scientific (NYSE:TMO) are both business services companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Volatility and Risk Mirion Technologies has a beta of -0.03, suggesting that its share []

Eudaimonia Partners LLC lessened its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 35.2% in the third quarter, according to its most recent filing with the SEC. The firm owned 507 shares of the medical research companys stock after selling 275 shares during the period. Eudaimonia Partners LLCs holdings in Thermo Fisher Scientific []

JJJ Advisors Inc. increased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 19.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 118 shares of the medical research companys stock after buying an additional 19 shares during the period. JJJ Advisors Inc.s holdings []

Wall Street brokerages expect that Thermo Fisher Scientific Inc. (NYSE:TMO) will report sales of $8.62 billion for the current fiscal quarter, according to Zacks Investment Research. Five analysts have provided estimates for Thermo Fisher Scientific’s earnings, with the lowest sales estimate coming in at $8.57 billion and the highest estimate coming in at $8.69 billion. […] The post $8.62 Billion in Sales Expected for Thermo Fisher Scientific Inc. (NYSE:TMO) This Quarter appeared first on ETF Daily News .

Convergence Investment Partners LLC increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 2.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 805 shares of the medical research companys stock after purchasing an additional 21 shares during the period. []

Cardan Capital Partners LLC lifted its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 7.1% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 705 shares of the medical research companys stock after buying an additional 47 shares during the period. []

Global Blood Testing Services Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of

Related Stocks: CHD , TMO , ICLR , FIS , ROST , FTV ,

DUBLIN--(BUSINESS WIRE)--The "Global Peptone Market" report has been added to ResearchAndMarkets.com''s offering. Peptone is used as a microbial growth medium that is generally prepared from sodium chloride & animal tissue. It can be derived from casein & plants, used in their hydrolyzed form to facilitate employment in culture medium. Peptone can be obtained from various sources of meat, soy, pea, gelatin, potato, wheat, and others. Companies Mentioned Thermo Fisher Scientific Inc Sigma

S. R. Schill & Associates purchased a new position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 365 shares of the medical research companys stock, valued at approximately $209,000. Several other institutional investors have also []

Microscopy Market report provides an in-depth overview of Product Specification, technology, product type, and production analysis considering major factors such as Revenue, Cost, Gross, and Gross Margin. This study also analyzes the market status, market share, growth rate, future trends,

Spire Wealth Management boosted its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 0.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,301 shares of the medical research companys stock after purchasing an additional 18 shares during the quarter. Spire Wealth Managements holdings in []

The global Treatment for H Pylori market size is projected to reach US$ 249.4 million by 2027, at a CAGR of 8.3% during 2021-2027. Infections with Helicobacter pylori are particularly common in underdeveloped countries. The spread of these illnesses can

Induced Pluripotent Stem Cell (iPSC) Market 2021 report helps the clients to take business decisions and to understand strategies of major players in the industry. The report also calls for market- driven results deriving feasibility studies for client needs. Market